{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:18:25Z","timestamp":1792523905283,"version":"4.5.0"},"reference-count":481,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1553,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1124\/pr.120.019554","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T23:30:13Z","timestamp":1600126213000},"page":"862-898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":387,"title":["RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges"],"prefix":"10.1016","volume":"72","author":[{"given":"Ai-Ming","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Juan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.120.019554_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/15476286.2015.1017234","article-title":"Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy","volume":"12","author":"Aaldering","year":"2015","journal-title":"RNA Biol"},{"key":"10.1124\/pr.120.019554_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/nat.2017.0665","article-title":"FDA approval of nusinersen for spinal muscular atrophy makes 2016 the year of splice modulating oligonucleotides","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther"},{"key":"10.1124\/pr.120.019554_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2016.0657","article-title":"FDA approves eteplirsen for Duchenne muscular dystrophy: the next chapter in the eteplirsen saga","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther"},{"key":"10.1124\/pr.120.019554_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI84424","article-title":"Targeting noncoding RNAs in disease","volume":"127","author":"Adams","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.120.019554_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clim.2011.10.010","article-title":"A phase I\/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption","volume":"142","author":"Allard","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1124\/pr.120.019554_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ebiom.2019.07.003","article-title":"Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia","volume":"45","author":"An","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1124\/pr.120.019554_bib11","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.celrep.2017.11.081","article-title":"Systemic messenger RNA therapy as a treatment for methylmalonic acidemia","volume":"21","author":"An","year":"2017","journal-title":"Cell Rep"},{"key":"10.1124\/pr.120.019554_bib12","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib13","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1073\/pnas.1901484116","article-title":"Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model","volume":"116","author":"Angelbello","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib14","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/nar\/gkh583","article-title":"Mapping of the second tetracycline binding site on the ribosomal small subunit of E.coli","volume":"32","author":"Anokhina","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34 - a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front Genet"},{"key":"10.1124\/pr.120.019554_bib17","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-10-2010","article-title":"The promise of microRNA replacement therapy","volume":"70","author":"Bader","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/pr.120.019554_bib18","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1073\/pnas.191268798","article-title":"Structural features of an influenza virus promoter and their implications for viral RNA synthesis","volume":"98","author":"Bae","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.cell.2005.07.031","article-title":"Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation","volume":"122","author":"Bagga","year":"2005","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.289.5481.905","article-title":"The complete atomic structure of the large ribosomal subunit at 2.4 A resolution","volume":"289","author":"Ban","year":"2000","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib22","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-59745-248-9_3","article-title":"Synthesis of RNA by in vitro transcription","volume":"703","author":"Beckert","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.120.019554_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Invest New Drugs"},{"key":"10.1124\/pr.120.019554_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1124\/pr.120.019554_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib27","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/JB.185.14.4276-4279.2003","article-title":"Structural insight into the antibiotic action of telithromycin against resistant mutants","volume":"185","author":"Berisio","year":"2003","journal-title":"J Bacteriol"},{"key":"10.1124\/pr.120.019554_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/35053110","article-title":"Role for a bidentate ribonuclease in the initiation step of RNA interference","volume":"409","author":"Bernstein","year":"2001","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nmeth854","article-title":"3\u2032 UTR seed matches, but not overall identity, are associated with RNAi off-targets","volume":"3","author":"Birmingham","year":"2006","journal-title":"Nat Methods"},{"key":"10.1124\/pr.120.019554_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nchembio842","article-title":"Antibacterial lysine analogs that target lysine riboswitches","volume":"3","author":"Blount","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pr.120.019554_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1261\/rna.5167604","article-title":"Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs","volume":"10","author":"Bohnsack","year":"2004","journal-title":"RNA"},{"key":"10.1124\/pr.120.019554_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cbdd.12534","article-title":"Targeting influenza A virus RNA promoter","volume":"86","author":"Bottini","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1124\/pr.120.019554_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.010909.105547","article-title":"Discovery and development of therapeutic aptamers","volume":"50","author":"Bouchard","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pr.120.019554_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2018.08.004","article-title":"Application of aptamers for in vivo molecular imaging and theranostics","volume":"134","author":"Bouvier-M\u00fcller","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/pr.120.019554_bib35","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/bph.13433","article-title":"Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects","volume":"173","author":"Boyce","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.120.019554_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fgene.2012.00154","article-title":"Development of therapeutic-grade small interfering RNAs by chemical engineering","volume":"3","author":"Bramsen","year":"2012","journal-title":"Front Genet"},{"key":"10.1124\/pr.120.019554_bib37","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","article-title":"The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit","volume":"103","author":"Brodersen","year":"2000","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.1068999","article-title":"A system for stable expression of short interfering RNAs in mammalian cells","volume":"296","author":"Brummelkamp","year":"2002","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/344540a0","article-title":"Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3","volume":"344","author":"Brzustowicz","year":"1990","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib40","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1073\/pnas.1008685107","article-title":"Revisiting the structures of several antibiotics bound to the bacterial ribosome","volume":"107","author":"Bulkley","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrmicro1458","article-title":"Aptamers come of age - at last","volume":"4","author":"Bunka","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/pr.120.019554_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamapediatrics.2017.4409","article-title":"Ethical challenges confronted when providing nusinersen treatment for spinal muscular atrophy","volume":"172","author":"Burgart","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1124\/pr.120.019554_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","article-title":"RNA-based therapeutics: current progress and future prospects","volume":"19","author":"Burnett","year":"2012","journal-title":"Chem Biol"},{"key":"10.1124\/pr.120.019554_bib44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1124\/pr.120.019554_bib45","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/ar200098t","article-title":"The molecular interactions that stabilize RNA tertiary structure: RNA motifs, patterns, and networks","volume":"44","author":"Butcher","year":"2011","journal-title":"Acc Chem Res"},{"key":"10.1124\/pr.120.019554_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0165-022X(90)90084-P","article-title":"Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid","volume":"20","author":"Campbell","year":"1990","journal-title":"J Biochem Biophys Methods"},{"key":"10.1124\/pr.120.019554_bib47","doi-asserted-by":"crossref","first-page":"D195","DOI":"10.1093\/nar\/gkq1028","article-title":"The RNA modification database, RNAMDB: 2011 update","volume":"39","author":"Cantara","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib48","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/cbic.201000177","article-title":"A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site","volume":"11","author":"Carnevali","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1124\/pr.120.019554_bib49","first-page":"36","article-title":"Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease","volume":"48","author":"Caron","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","article-title":"The promises and pitfalls of RNA-interference-based therapeutics","volume":"457","author":"Castanotto","year":"2009","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib51","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1038\/ncomms13892","article-title":"Transcriptional pausing at the translation start site operates as a critical checkpoint for riboswitch regulation","volume":"8","author":"Chauvier","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/pr.120.019554_bib52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Cheloufi","year":"2010","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib53","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1093\/nar\/gni178","article-title":"Real-time quantification of microRNAs by stem-loop RT-PCR","volume":"33","author":"Chen","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib54","doi-asserted-by":"crossref","first-page":"e1609","DOI":"10.1002\/wnan.1609","article-title":"Strategies for nonviral nanoparticle-based delivery of CRISPR\/Cas9 therapeutics","volume":"12","author":"Chen","year":"2020","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1124\/pr.120.019554_bib55","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1093\/nar\/gkv228","article-title":"A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications","volume":"43","author":"Chen","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib56","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1021\/acs.jmedchem.8b01291","article-title":"Discovery of small molecule splicing modulators of survival motor neuron-2 (SMN2) for the treatment of spinal muscular atrophy (SMA)","volume":"61","author":"Cheung","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/pr.120.019554_bib57","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1073\/pnas.1037853100","article-title":"Genomewide view of gene silencing by small interfering RNAs","volume":"100","author":"Chi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib58","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.1190809","article-title":"A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity","volume":"328","author":"Cifuentes","year":"2010","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/pr.120.019554_bib60","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00415-019-09671-9","article-title":"Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis","volume":"267","author":"Coelho","year":"2020","journal-title":"J Neurol"},{"key":"10.1124\/pr.120.019554_bib61","doi-asserted-by":"crossref","first-page":"30398","DOI":"10.1074\/jbc.271.48.30398","article-title":"Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells","volume":"271","author":"Condon","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.120.019554_bib62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib63","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.chembiol.2016.05.021","article-title":"The emerging role of RNA as a therapeutic target for small molecules","volume":"23","author":"Connelly","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1124\/pr.120.019554_bib64","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2019.03.003","article-title":"Non-viral delivery of zinc finger nuclease mRNA enables highly efficient in vivo genome editing of multiple therapeutic gene targets","volume":"27","author":"Conway","year":"2019","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib65","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.abc5312","article-title":"A strategic approach to COVID-19 vaccine R&D","volume":"368","author":"Corey","year":"2020","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib66","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b01927","article-title":"How we think about targeting RNA with small molecules","author":"Costales","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/pr.120.019554_bib67","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1021\/jacs.6b11273","article-title":"Small molecule inhibition of microRNA-210 reprograms an oncogenic hypoxic circuit","volume":"139","author":"Costales","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib68","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1021\/jacs.8b10558","article-title":"A designed small molecule inhibitor of a non-coding RNA sensitizes HER2 negative cancers to herceptin","volume":"141","author":"Costales","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib69","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.chembiol.2019.04.008","article-title":"Targeted degradation of a hypoxia-associated non-coding RNA enhances the selectivity of a small molecule interacting with RNA","volume":"26","author":"Costales","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1124\/pr.120.019554_bib70","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/leu.2012.110","article-title":"Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo","volume":"26","author":"Craig","year":"2012","journal-title":"Leukemia"},{"key":"10.1124\/pr.120.019554_bib71","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ymthe.2018.06.002","article-title":"Global transcriptional response to CRISPR\/Cas9-AAV6-based genome editing in CD34+ hematopoietic stem and progenitor cells","volume":"26","author":"Cromer","year":"2018","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2125.2012.04469.x","article-title":"Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B","volume":"76","author":"Crooke","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.120.019554_bib73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab"},{"key":"10.1124\/pr.120.019554_bib74","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.cell.2009.02.003","article-title":"The dynamic landscapes of RNA architecture","volume":"136","author":"Cruz","year":"2009","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib75","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nat Nanotechnol"},{"key":"10.1124\/pr.120.019554_bib76","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4161\/rna.20206","article-title":"RNA mediated Toll-like receptor stimulation in health and disease","volume":"9","author":"Dalpke","year":"2012","journal-title":"RNA Biol"},{"key":"10.1124\/pr.120.019554_bib77","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2147\/TCRM.S172291","article-title":"Clinical evidence supporting early treatment of patients with spinal muscular atrophy: current perspectives","volume":"15","author":"Dangouloff","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"10.1124\/pr.120.019554_bib78","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4155\/tde.13.118","article-title":"Current progress on aptamer-targeted oligonucleotide therapeutics","volume":"4","author":"Dassie","year":"2013","journal-title":"Ther Deliv"},{"key":"10.1124\/pr.120.019554_bib79","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/M16-0291","article-title":"Progress in the fight against multidrug-resistant bacteria? A review of U.S. Food and Drug Administration-approved antibiotics, 2010-2015","volume":"165","author":"Deak","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1124\/pr.120.019554_bib81","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13063-019-3409-1","article-title":"iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy","volume":"20","author":"de Jong","year":"2019","journal-title":"Trials"},{"key":"10.1124\/pr.120.019554_bib82","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature10913","article-title":"A new understanding of the decoding principle on the ribosome","volume":"484","author":"Demeshkina","year":"2012","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib83","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ncomms2346","article-title":"A structural basis for streptomycin-induced misreading of the genetic code","volume":"4","author":"Demirci","year":"2013","journal-title":"Nat Commun"},{"key":"10.1124\/pr.120.019554_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2016.11.010","article-title":"SDF-1 blockade enhances anti-VEGF therapy of glioblastoma and can be monitored by MRI","volume":"19","author":"Deng","year":"2017","journal-title":"Neoplasia"},{"key":"10.1124\/pr.120.019554_bib85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40291-019-00438-6","article-title":"Leading RNA interference therapeutics part 2: silencing delta-aminolevulinic acid synthase 1, with a focus on givosiran","volume":"24","author":"de Paula Brandao","year":"2020","journal-title":"Mol Diagn Ther"},{"key":"10.1124\/pr.120.019554_bib87","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib88","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib89","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1073\/pnas.1118699109","article-title":"Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches","volume":"109","author":"Dibrov","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib90","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1021\/jm401312n","article-title":"Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site","volume":"57","author":"Dibrov","year":"2014","journal-title":"J Med Chem"},{"key":"10.1124\/pr.120.019554_bib91","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1039\/C9MD00195F","article-title":"Synthetic small-molecule RNA ligands: future prospects as therapeutic agents","volume":"10","author":"Di Giorgio","year":"2019","journal-title":"MedChemComm"},{"key":"10.1124\/pr.120.019554_bib92","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1021\/cb300135h","article-title":"A small molecule that targets r(CGG)(exp) and improves defects in fragile X-associated tremor ataxia syndrome","volume":"7","author":"Disney","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pr.120.019554_bib93","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1021\/acschembio.6b00001","article-title":"Inforna 2.0: a platform for the sequence-based design of small molecules targeting structured RNAs","volume":"11","author":"Disney","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pr.120.019554_bib94","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib95","doi-asserted-by":"crossref","first-page":"e1477","DOI":"10.1002\/wrna.1477","article-title":"Targeting RNA in mammalian systems with small molecules","volume":"9","author":"Donlic","year":"2018","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1124\/pr.120.019554_bib96","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib97","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.omtn.2018.07.010","article-title":"Splice-modulating oligonucleotide QR-110 restores CEP290 mRNA and function in human c.2991+1655A>G LCA10 models","volume":"12","author":"Dulla","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1124\/pr.120.019554_bib98","doi-asserted-by":"crossref","first-page":"17152","DOI":"10.1073\/pnas.1007988107","article-title":"Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action","volume":"107","author":"Dunkle","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib99","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.83.15.5372","article-title":"Inhibition of gene expression in plant cells by expression of antisense RNA","volume":"83","author":"Ecker","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.bi.54.070185.002055","article-title":"Nucleoside phosphorothioates","volume":"54","author":"Eckstein","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pr.120.019554_bib101","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib102","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib103","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1093\/nar\/gkx094","article-title":"A transposon-derived small RNA regulates gene expression in Salmonella Typhimurium","volume":"45","author":"Ellis","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib104","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.molcel.2008.10.017","article-title":"A human snoRNA with microRNA-like functions","volume":"32","author":"Ender","year":"2008","journal-title":"Mol Cell"},{"key":"10.1124\/pr.120.019554_bib105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1124\/pr.120.019554_bib106","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","article-title":"AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a Huntington\u2019s disease minipig model","volume":"26","author":"Evers","year":"2018","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib107","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nano.2016.08.005","article-title":"Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo","volume":"13","author":"Ewe","year":"2017","journal-title":"Nanomedicine (Lond)"},{"key":"10.1124\/pr.120.019554_bib108","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.actbio.2014.02.037","article-title":"Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery","volume":"10","author":"Ewe","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1124\/pr.120.019554_bib109","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4155\/bio.13.319","article-title":"Quantification of oligonucleotides by LC-MS\/MS: the challenges of quantifying a phosphorothioate oligonucleotide and multiple metabolites","volume":"6","author":"Ewles","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1124\/pr.120.019554_bib110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib111","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cgt.2016.4","article-title":"Precise and efficient siRNA design: a key point in competent gene silencing","volume":"23","author":"Fakhr","year":"2016","journal-title":"Cancer Gene Ther"},{"key":"10.1124\/pr.120.019554_bib112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/334165a0","article-title":"HIV-1 tat trans-activation requires the loop sequence within tar","volume":"334","author":"Feng","year":"1988","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib113","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3389\/fmicb.2018.00559","article-title":"Structural and functional motifs in influenza virus RNAs","volume":"9","author":"Ferhadian","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1124\/pr.120.019554_bib114","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biochi.2019.09.003","article-title":"Guide RNA modification as a way to improve CRISPR\/Cas9-based genome-editing systems","volume":"167","author":"Filippova","year":"2019","journal-title":"Biochimie"},{"key":"10.1124\/pr.120.019554_bib115","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib116","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib117","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(13)61914-5","article-title":"Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial","volume":"383","author":"Fitzgerald","year":"2014","journal-title":"Lancet"},{"key":"10.1124\/pr.120.019554_bib118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"Fotin-Mleczek","year":"2011","journal-title":"J Immunother"},{"key":"10.1124\/pr.120.019554_bib120","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1126\/science.274.5291.1367","article-title":"Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic","volume":"274","author":"Fourmy","year":"1996","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib121","doi-asserted-by":"crossref","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy","volume":"94","author":"Frank","year":"2020","journal-title":"Neurology"},{"key":"10.1124\/pr.120.019554_bib122","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nbt.3101","article-title":"Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases","volume":"33","author":"Frock","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib123","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000000852","article-title":"Immunization of HIV-1-infected persons with autologous dendritic cells transfected with mRNA encoding HIV-1 Gag and Nef: results of a randomized, placebo-controlled clinical trial","volume":"71","author":"Gandhi","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1124\/pr.120.019554_bib124","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41594-018-0062-4","article-title":"High-performance virtual screening by targeting a high-resolution RNA dynamic ensemble","volume":"25","author":"Ganser","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/pr.120.019554_bib125","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/MMBR.00027-06","article-title":"Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action","volume":"70","author":"Garc\u00eda","year":"2006","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1124\/pr.120.019554_bib126","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1084\/jem.20111044","article-title":"Identification of modifications in microbial, native tRNA that suppress immunostimulatory activity","volume":"209","author":"Gehrig","year":"2012","journal-title":"J Exp Med"},{"key":"10.1124\/pr.120.019554_bib127","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ymthe.2018.02.025","article-title":"Long terminal repeat CRISPR-CAR-coupled \u201cuniversal\u201d T cells mediate potent anti-leukemic effects","volume":"26","author":"Georgiadis","year":"2018","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1126\/science.1172447","article-title":"Knockout rats via embryo microinjection of zinc-finger nucleases","volume":"325","author":"Geurts","year":"2009","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib129","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.18632\/oncotarget.4183","article-title":"RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients","volume":"6","author":"Golan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1124\/pr.120.019554_bib130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00006982-200510000-00001","article-title":"Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis","volume":"25","author":"Gonzales","year":"2005","journal-title":"Retina"},{"key":"10.1124\/pr.120.019554_bib131","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2172-10-40","article-title":"Sequence determinants of innate immune activation by short interfering RNAs","volume":"10","author":"Goodchild","year":"2009","journal-title":"BMC Immunol"},{"key":"10.1124\/pr.120.019554_bib132","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib133","doi-asserted-by":"crossref","first-page":"18624","DOI":"10.1074\/jbc.RA119.009951","article-title":"High-throughput screening yields several small-molecule inhibitors of repeat-associated non-AUG translation","volume":"294","author":"Green","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.120.019554_bib134","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature03120","article-title":"The Microprocessor complex mediates the genesis of microRNAs","volume":"432","author":"Gregory","year":"2004","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib135","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.addr.2005.09.009","article-title":"Regulatory aspects of drug approval for macular degeneration","volume":"57","author":"Gryziewicz","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/pr.120.019554_bib136","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/cb200447r","article-title":"Recent advances in developing small molecules targeting RNA","volume":"7","author":"Guan","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pr.120.019554_bib137","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/s41596-019-0187-x","article-title":"Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD","volume":"14","author":"Gurumurthy","year":"2019","journal-title":"Nat Protoc"},{"key":"10.1124\/pr.120.019554_bib138","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2014.11.011","article-title":"European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene","volume":"25","author":"Haas","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1124\/pr.120.019554_bib139","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.embor.7400509","article-title":"TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing","volume":"6","author":"Haase","year":"2005","journal-title":"EMBO Rep"},{"key":"10.1124\/pr.120.019554_bib140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-biochem-060815-014628","article-title":"Engineering and in vivo applications of riboswitches","volume":"86","author":"Hallberg","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pr.120.019554_bib141","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/35005107","article-title":"An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells","volume":"404","author":"Hammond","year":"2000","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib142","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1126\/science.1064023","article-title":"Argonaute2, a link between genetic and biochemical analyses of RNAi","volume":"293","author":"Hammond","year":"2001","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib143","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 complex in primary microRNA processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes Dev"},{"key":"10.1124\/pr.120.019554_bib144","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1097-2765(02)00570-1","article-title":"The structures of four macrolide antibiotics bound to the large ribosomal subunit","volume":"10","author":"Hansen","year":"2002","journal-title":"Mol Cell"},{"key":"10.1124\/pr.120.019554_bib145","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1007\/s00253-019-10113-9","article-title":"Construction of Corynebacterium glutamicum cells as containers encapsulating dsRNA overexpressed for agricultural pest control","volume":"103","author":"Hashiro","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1124\/pr.120.019554_bib146","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jbiosc.2019.03.003","article-title":"Overexpression system for recombinant RNA in Corynebacterium glutamicum using a strong promoter derived from corynephage BFK20","volume":"128","author":"Hashiro","year":"2019","journal-title":"J Biosci Bioeng"},{"key":"10.1124\/pr.120.019554_bib147","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1124\/pr.120.019554_bib148","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/dbio.2000.9720","article-title":"Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach","volume":"222","author":"Heasman","year":"2000","journal-title":"Dev Biol"},{"key":"10.1124\/pr.120.019554_bib149","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI0214364","article-title":"Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors","volume":"109","author":"Heiser","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.120.019554_bib150","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib151","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrm.2017.130","article-title":"A brave new world of RNA-binding proteins","volume":"19","author":"Hentze","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/pr.120.019554_bib152","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40265-020-01267-2","article-title":"Golodirsen: first approval","volume":"80","author":"Heo","year":"2020","journal-title":"Drugs"},{"key":"10.1124\/pr.120.019554_bib153","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/wrna.1373","article-title":"Small molecules targeting viral RNA","volume":"7","author":"Hermann","year":"2016","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1124\/pr.120.019554_bib154","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/jpet.118.247775","article-title":"Bioengineered noncoding RNAs selectively change cellular miRNome profiles for cancer therapy","volume":"365","author":"Ho","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.120.019554_bib155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wrna.1324","article-title":"Bioengineering of noncoding RNAs for research agents and therapeutics","volume":"7","author":"Ho","year":"2016","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1124\/pr.120.019554_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#","article-title":"In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies","volume":"30","author":"Hoerr","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1124\/pr.120.019554_bib157","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib158","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3389\/fphys.2018.01262","article-title":"Circular RNAs as therapeutic agents and targets","volume":"9","author":"Holdt","year":"2018","journal-title":"Front Physiol"},{"key":"10.1124\/pr.120.019554_bib159","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1124\/pr.120.019554_bib160","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5\u2032-Triphosphate RNA is the ligand for RIG-I","volume":"314","author":"Hornung","year":"2006","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib161","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cell.2009.01.019","article-title":"The many pathways of RNA degradation","volume":"136","author":"Houseley","year":"2009","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib162","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nature15542","article-title":"Selective small-molecule inhibition of an RNA structural element","volume":"526","author":"Howe","year":"2015","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib163","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1080\/15476286.2016.1216304","article-title":"Atomic resolution mechanistic studies of ribocil: a highly selective unnatural ligand mimic of the E. coli FMN riboswitch","volume":"13","author":"Howe","year":"2016","journal-title":"RNA Biol"},{"key":"10.1124\/pr.120.019554_bib164","doi-asserted-by":"crossref","first-page":"302","DOI":"10.14348\/molcells.2014.2209","article-title":"Disruption of the myostatin gene in porcine primary fibroblasts and embryos using zinc-finger nucleases","volume":"37","author":"Huang","year":"2014","journal-title":"Mol Cells"},{"key":"10.1124\/pr.120.019554_bib165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/OPTH.S5156","article-title":"Age-related macular degeneration: experimental and emerging treatments","volume":"3","author":"Hubschman","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"10.1124\/pr.120.019554_bib166","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1124\/dmd.119.086967","article-title":"Plasma and liver protein binding of N-acetylgalactosamine-conjugated small interfering RNA","volume":"47","author":"Humphreys","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.120.019554_bib167","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1021\/acs.analchem.7b01244","article-title":"Identification of GalNAc-conjugated antisense oligonucleotide metabolites using an untargeted and generic approach based on high resolution mass spectrometry","volume":"89","author":"Husser","year":"2017","journal-title":"Anal Chem"},{"key":"10.1124\/pr.120.019554_bib168","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1062961","article-title":"A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA","volume":"293","author":"Hutv\u00e1gner","year":"2001","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib169","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1126\/science.1073827","article-title":"A microRNA in a multiple-turnover RNAi enzyme complex","volume":"297","author":"Hutv\u00e1gner","year":"2002","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib170","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/jm800379d","article-title":"Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit","volume":"51","author":"Ippolito","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/pr.120.019554_bib171","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nprot.2014.009","article-title":"Germline transgenesis in rabbits by pronuclear microinjection of Sleeping Beauty transposons","volume":"9","author":"Ivics","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1124\/pr.120.019554_bib172","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nprot.2014.008","article-title":"Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons","volume":"9","author":"Ivics","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1124\/pr.120.019554_bib173","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0092-8674(84)90050-3","article-title":"Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis","volume":"36","author":"Izant","year":"1984","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib174","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib175","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1261\/rna.25706","article-title":"Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity","volume":"12","author":"Jackson","year":"2006","journal-title":"RNA"},{"key":"10.1124\/pr.120.019554_bib176","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd3010","article-title":"Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application","volume":"9","author":"Jackson","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.120.019554_bib177","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41467-018-02989-4","article-title":"Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity","volume":"9","author":"Janas","year":"2018","journal-title":"Nat Commun"},{"key":"10.1124\/pr.120.019554_bib178","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","article-title":"Identification of genes that are associated with DNA repeats in prokaryotes","volume":"43","author":"Jansen","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1124\/pr.120.019554_bib179","doi-asserted-by":"crossref","first-page":"30742","DOI":"10.18632\/oncotarget.16372","article-title":"Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models","volume":"8","author":"Jian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/pr.120.019554_bib180","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1124\/dmd.116.074344","article-title":"Effects of microRNA-34a on the pharmacokinetics of cytochrome P450 probe drugs in mice","volume":"45","author":"Jilek","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.120.019554_bib181","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.omtn.2019.01.007","article-title":"Bioengineered Let-7c inhibits orthotopic hepatocellular carcinoma and improves overall survival with minimal immunogenicity","volume":"14","author":"Jilek","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1124\/pr.120.019554_bib182","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib183","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.02.004","article-title":"RNA quaternary structure and global symmetry","volume":"40","author":"Jones","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/pr.120.019554_bib184","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: from concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Med"},{"key":"10.1124\/pr.120.019554_bib185","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat Mater"},{"key":"10.1124\/pr.120.019554_bib186","doi-asserted-by":"crossref","first-page":"12529","DOI":"10.1093\/nar\/gkx882","article-title":"A structural basis for the antibiotic resistance conferred by an N1-methylation of A1408 in 16S rRNA","volume":"45","author":"Kanazawa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib187","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1124\/pr.120.019554_bib188","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib189","first-page":"523","article-title":"Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development","volume":"10","author":"Karik\u00f3","year":"2007","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1124\/pr.120.019554_bib190","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1158\/0008-5472.CAN-12-2001","article-title":"miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma","volume":"72","author":"Kasinski","year":"2012","journal-title":"Cancer Res"},{"key":"10.1124\/pr.120.019554_bib191","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1021\/jacs.6b04506","article-title":"A small molecule that represses translation of G-quadruplex-containing mRNA","volume":"138","author":"Katsuda","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib192","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.09.006","article-title":"Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo","volume":"109","author":"Kauffman","year":"2016","journal-title":"Biomaterials"},{"key":"10.1124\/pr.120.019554_bib193","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.7150\/thno.25958","article-title":"Aptamers in the therapeutics and diagnostics pipelines","volume":"8","author":"Kaur","year":"2018","journal-title":"Theranostics"},{"key":"10.1124\/pr.120.019554_bib194","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.120.019554_bib195","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s40265-018-0968-5","article-title":"Inotersen: first global approval","volume":"78","author":"Keam","year":"2018","journal-title":"Drugs"},{"key":"10.1124\/pr.120.019554_bib196","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1021\/ac403044t","article-title":"Quantification of therapeutic miRNA mimics in whole blood from nonhuman primates","volume":"86","author":"Kelnar","year":"2014","journal-title":"Anal Chem"},{"key":"10.1124\/pr.120.019554_bib197","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtm.2019.09.010","article-title":"AAV5-miHTT lowers Huntingtin mRNA and protein without off-target effects in patient-derived neuronal cultures and astrocytes","volume":"15","author":"Keskin","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1124\/pr.120.019554_bib198","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/JND-180351","article-title":"Eteplirsen treatment attenuates respiratory decline in ambulatory and non-ambulatory patients with Duchenne muscular dystrophy","volume":"6","author":"Khan","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"10.1124\/pr.120.019554_bib199","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib201","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt1051","article-title":"Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy","volume":"23","author":"Kim","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib202","doi-asserted-by":"crossref","first-page":"14406","DOI":"10.1038\/ncomms14406","article-title":"CRISPR\/Cpf1-mediated DNA-free plant genome editing","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/pr.120.019554_bib203","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06765","article-title":"Sequence- and target-independent angiogenesis suppression by siRNA via TLR3","volume":"452","author":"Kleinman","year":"2008","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib204","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00280-004-0968-x","article-title":"Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors","volume":"56","author":"Kobayashi","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/pr.120.019554_bib205","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1073\/pnas.76.8.3795","article-title":"Reconstitution of RNase P activity from inactive RNA and protein","volume":"76","author":"Kole","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrd3625","article-title":"RNA therapeutics: beyond RNA interference and antisense oligonucleotides","volume":"11","author":"Kole","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.120.019554_bib207","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/anie.201106084","article-title":"A structural basis for the antibiotic resistance conferred by an A1408G mutation in 16S rRNA and for the antiprotozoal activity of aminoglycosides","volume":"51","author":"Kondo","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pr.120.019554_bib208","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib209","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib210","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib211","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1213\/ANE.0000000000002444","article-title":"MicroRNAs as clinical biomarkers and therapeutic tools in perioperative medicine","volume":"126","author":"Kreth","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1124\/pr.120.019554_bib212","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0092-8674(82)90414-7","article-title":"Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena","volume":"31","author":"Kruger","year":"1982","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib213","doi-asserted-by":"crossref","first-page":"38892","DOI":"10.1074\/jbc.M301939200","article-title":"The apical loop of the HIV-1 TAR RNA hairpin is stabilized by a cross-loop base pair","volume":"278","author":"Kulinski","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.120.019554_bib214","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1261\/rna.066126.118","article-title":"tRNA fragments (tRFs) guide Ago to regulate gene expression post-transcriptionally in a Dicer-independent manner","volume":"24","author":"Kuscu","year":"2018","journal-title":"RNA"},{"key":"10.1124\/pr.120.019554_bib215","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","article-title":"Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery","volume":"65","author":"Landen","year":"2005","journal-title":"Cancer Res"},{"key":"10.1124\/pr.120.019554_bib216","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1097\/QAD.0000000000002026","article-title":"Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection","volume":"32","author":"Leal","year":"2018","journal-title":"AIDS"},{"key":"10.1124\/pr.120.019554_bib217","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4161\/rna.6.2.7727","article-title":"Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression","volume":"6","author":"Lee","year":"2009","journal-title":"RNA Biol"},{"key":"10.1124\/pr.120.019554_bib218","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1039\/C3CC46973E","article-title":"A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication","volume":"50","author":"Lee","year":"2014","journal-title":"Chem Commun (Camb)"},{"key":"10.1124\/pr.120.019554_bib219","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib221","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1093\/emboj\/cdf476","article-title":"MicroRNA maturation: stepwise processing and subcellular localization","volume":"21","author":"Lee","year":"2002","journal-title":"EMBO J"},{"key":"10.1124\/pr.120.019554_bib222","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA genes are transcribed by RNA polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J"},{"key":"10.1124\/pr.120.019554_bib223","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib224","first-page":"147","article-title":"Targeting the HIV RNA genome: high-hanging fruit only needs a longer ladder","volume":"389","author":"Le Grice","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1124\/pr.120.019554_bib225","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/nar\/gkv1206","article-title":"Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides","volume":"44","author":"Lennox","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib226","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1124\/pr.120.019554_bib227","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJMra1705346","article-title":"Treating disease at the RNA level with oligonucleotides","volume":"380","author":"Levin","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib228","doi-asserted-by":"crossref","first-page":"18115","DOI":"10.1002\/chem.201804368","article-title":"A dimeric 2,9-diamino-1,10-phenanthroline derivative improves alternative splicing in myotonic dystrophy type 1 cell and mouse models","volume":"24","author":"Li","year":"2018","journal-title":"Chemistry"},{"key":"10.1124\/pr.120.019554_bib229","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/dmd.115.064493","article-title":"Chimeric microRNA-1291 biosynthesized efficiently in Escherichia coli is effective to reduce target gene expression in human carcinoma cells and improve chemosensitivity","volume":"43","author":"Li","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.120.019554_bib230","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1124\/dmd.114.060145","article-title":"Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells","volume":"42","author":"Li","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.120.019554_bib231","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/dmd.117.078741","article-title":"Bioengineered NRF2-siRNA is effective to interfere with NRF2 pathways and improve chemosensitivity of human cancer cells","volume":"46","author":"Li","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.120.019554_bib232","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.apsb.2018.12.002","article-title":"Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/pr.120.019554_bib233","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/acschembio.8b00827","article-title":"Precise small molecule degradation of a noncoding RNA identifies cellular binding sites and modulates an oncogenic phenotype","volume":"13","author":"Li","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pr.120.019554_bib234","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13238-015-0153-5","article-title":"CRISPR\/Cas9-mediated gene editing in human tripronuclear zygotes","volume":"6","author":"Liang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1124\/pr.120.019554_bib235","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41594-018-0054-4","article-title":"Tapping the RNA world for therapeutics","volume":"25","author":"Lieberman","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/pr.120.019554_bib236","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1681\/ASN.2016030338","article-title":"An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria","volume":"28","author":"Liebow","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.120.019554_bib237","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/j.1460-2075.1983.tb01387.x","article-title":"Post-transcriptional control of expression of the repA gene of plasmid R1 mediated by a small RNA molecule","volume":"2","author":"Light","year":"1983","journal-title":"EMBO J"},{"key":"10.1124\/pr.120.019554_bib238","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/nar\/22.12.2183","article-title":"Summary: the modified nucleosides of RNA","volume":"22","author":"Limbach","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib239","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-biochem-062917-011942","article-title":"Ribosome-targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design","volume":"87","author":"Lin","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pr.120.019554_bib240","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1146\/annurev-biochem-060409-092720","article-title":"Understanding nucleic acid-ion interactions","volume":"83","author":"Lipfert","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pr.120.019554_bib241","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1124\/pr.120.019554_bib242","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat Med"},{"key":"10.1124\/pr.120.019554_bib243","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1126\/science.1102513","article-title":"Argonaute2 is the catalytic engine of mammalian RNAi","volume":"305","author":"Liu","year":"2004","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib244","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/bio-2019-0137","article-title":"Oligonucleotide quantification and metabolite profiling by high-resolution and accurate mass spectrometry","volume":"11","author":"Liu","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1124\/pr.120.019554_bib245","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib246","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib247","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/leu.2017.5","article-title":"Olaptesed pegol, an anti-CXCL12\/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed\/refractory multiple myeloma: a Phase IIa Study","volume":"31","author":"Ludwig","year":"2017","journal-title":"Leukemia"},{"key":"10.1124\/pr.120.019554_bib248","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virusres.2008.06.004","article-title":"Structure and function of HCV IRES domains","volume":"139","author":"Lukavsky","year":"2009","journal-title":"Virus Res"},{"key":"10.1124\/pr.120.019554_bib249","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.1090599","article-title":"Nuclear export of microRNA precursors","volume":"303","author":"Lund","year":"2004","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib250","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/cmdc.201600081","article-title":"A potent inhibitor of protein sequestration by expanded triplet (CUG) repeats that shows phenotypic improvements in a Drosophila model of myotonic dystrophy","volume":"11","author":"Luu","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1124\/pr.120.019554_bib251","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J Control Release"},{"key":"10.1124\/pr.120.019554_bib252","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0969-2126(02)00934-6","article-title":"Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex","volume":"11","author":"Lynch","year":"2003","journal-title":"Structure"},{"key":"10.1124\/pr.120.019554_bib253","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1006\/jmbi.2000.4420","article-title":"Structural origins of aminoglycoside specificity for prokaryotic ribosomes","volume":"306","author":"Lynch","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1124\/pr.120.019554_bib254","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/JBM.S159297","article-title":"An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B","volume":"9","author":"Machin","year":"2018","journal-title":"J Blood Med"},{"key":"10.1124\/pr.120.019554_bib255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-6150-1-7","article-title":"A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action","volume":"1","author":"Makarova","year":"2006","journal-title":"Biol Direct"},{"key":"10.1124\/pr.120.019554_bib256","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib257","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1073\/pnas.87.9.3624","article-title":"Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus","volume":"87","author":"Marciniak","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib258","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0092-8674(02)00908-X","article-title":"Single-stranded antisense siRNAs guide target RNA cleavage in RNAi","volume":"110","author":"Martinez","year":"2002","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib259","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1089\/hum.2019.090","article-title":"A new era for rare genetic diseases: messenger RNA therapy","volume":"30","author":"Martini","year":"2019","journal-title":"Hum Gene Ther"},{"key":"10.1124\/pr.120.019554_bib260","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1038\/srep03355","article-title":"Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA","volume":"3","author":"Mashiko","year":"2013","journal-title":"Sci Rep"},{"key":"10.1124\/pr.120.019554_bib261","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2005.08.044","article-title":"Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes","volume":"123","author":"Matranga","year":"2005","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib262","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nrg1321","article-title":"RNA regulation: a new genetics?","volume":"5","author":"Mattick","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1124\/pr.120.019554_bib263","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2326-6066.CIR-13-0006","article-title":"T cells expressing chimeric antigen receptors can cause anaphylaxis in humans","volume":"1","author":"Maus","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1124\/pr.120.019554_bib264","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1073\/pnas.1206761110","article-title":"tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma","volume":"110","author":"Maute","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib265","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/sj.gt.3302800","article-title":"Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD","volume":"13","author":"McClorey","year":"2006","journal-title":"Gene Ther"},{"key":"10.1124\/pr.120.019554_bib266","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1261\/rna.061234.117","article-title":"Riboswitch diversity and distribution","volume":"23","author":"McCown","year":"2017","journal-title":"RNA"},{"key":"10.1124\/pr.120.019554_bib267","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet"},{"key":"10.1124\/pr.120.019554_bib268","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jchromb.2011.09.007","article-title":"Chromatographic methods for the determination of therapeutic oligonucleotides","volume":"883\u2013884","author":"McGinnis","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/pr.120.019554_bib269","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.aca.2013.08.040","article-title":"Ion exchange liquid chromatography method for the direct determination of small ribonucleic acids","volume":"799","author":"McGinnis","year":"2013","journal-title":"Anal Chim Acta"},{"key":"10.1124\/pr.120.019554_bib270","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ymthe.2018.02.031","article-title":"Chemically modified Cpf1-CRISPR RNAs mediate efficient genome editing in mammalian cells","volume":"26","author":"McMahon","year":"2018","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib271","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0968-0896(97)00064-3","article-title":"Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein\/TAR RNA complexes required for HIV-1 transcription","volume":"5","author":"Mei","year":"1997","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.120.019554_bib272","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","article-title":"Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs","volume":"15","author":"Meister","year":"2004","journal-title":"Mol Cell"},{"key":"10.1124\/pr.120.019554_bib273","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1124\/pr.120.019554_bib274","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1124\/pr.120.019554_bib275","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib276","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1021\/acs.jmedchem.7b00622","article-title":"RNA G-quadruplexes in Kirsten Ras (KRAS) oncogene as targets for small molecules inhibiting translation","volume":"60","author":"Miglietta","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/pr.120.019554_bib277","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.oret.2019.07.015","article-title":"Developing therapies for age-related macular degeneration: the art and science of problem-solving: the 2018 Charles L. Schepens, MD, Lecture","volume":"3","author":"Miller","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1124\/pr.120.019554_bib278","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1093\/nar\/15.21.8783","article-title":"Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates","volume":"15","author":"Milligan","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib279","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1038\/mtna.2016.7","article-title":"Design, characterization, and lead selection of therapeutic miRNAs targeting Huntingtin for development of gene therapy for Huntington\u2019s disease","volume":"5","author":"Miniarikova","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1124\/pr.120.019554_bib280","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gt.2017.71","article-title":"AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington\u2019s disease","volume":"24","author":"Miniarikova","year":"2017","journal-title":"Gene Ther"},{"key":"10.1124\/pr.120.019554_bib281","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(02)01134-0","article-title":"Sensing small molecules by nascent RNA: a mechanism to control transcription in bacteria","volume":"111","author":"Mironov","year":"2002","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib282","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1002\/anie.201707641","article-title":"Discovery of key physicochemical, structural, and spatial properties of RNA-targeted bioactive ligands","volume":"56","author":"Morgan","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pr.120.019554_bib283","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1093\/nar\/gky718","article-title":"Insights into the development of chemical probes for RNA","volume":"46","author":"Morgan","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib284","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1002\/cncr.26730","article-title":"An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer","volume":"118","author":"Morrow","year":"2012","journal-title":"Cancer"},{"key":"10.1124\/pr.120.019554_bib285","first-page":"47","article-title":"For patients who inherit homozygous familial hypercholesterolemia, 2 new treatments available","volume":"22","author":"Morrow","year":"2013","journal-title":"Manag Care"},{"key":"10.1124\/pr.120.019554_bib286","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cell.2018.02.034","article-title":"Pervasive regulatory functions of mRNA structure revealed by high-resolution SHAPE probing","volume":"173","author":"Mustoe","year":"2018","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib287","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1038\/ncomms12856","article-title":"Structure-function insights reveal the human ribosome as a cancer target for antibiotics","volume":"7","author":"Myasnikov","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/pr.120.019554_bib288","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1074-5521(02)00224-7","article-title":"Genetic control by a metabolite binding mRNA","volume":"9","author":"Nahvi","year":"2002","journal-title":"Chem Biol"},{"key":"10.1124\/pr.120.019554_bib289","doi-asserted-by":"crossref","first-page":"10969","DOI":"10.1093\/nar\/gkx818","article-title":"Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugates","volume":"45","author":"Nair","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib290","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib291","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fgene.2012.00102","article-title":"siRNA design software for a target gene-specific RNA interference","volume":"3","author":"Naito","year":"2012","journal-title":"Front Genet"},{"key":"10.1124\/pr.120.019554_bib292","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4161\/rna.5.3.6839","article-title":"A brilliant disguise for self RNA: 5\u2032-end and internal modifications of primary transcripts suppress elements of innate immunity","volume":"5","author":"Nallagatla","year":"2008","journal-title":"RNA Biol"},{"key":"10.1124\/pr.120.019554_bib293","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10495398.2016.1176032","article-title":"GRK5-knockout mice generated by TALEN-mediated gene targeting","volume":"27","author":"Nanjidsuren","year":"2016","journal-title":"Anim Biotechnol"},{"key":"10.1124\/pr.120.019554_bib294","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib295","doi-asserted-by":"crossref","first-page":"66ra6","DOI":"10.1126\/scitranslmed.3001581","article-title":"An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice","volume":"3","author":"Neff","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1124\/pr.120.019554_bib296","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib297","doi-asserted-by":"crossref","first-page":"14180","DOI":"10.1021\/jacs.5b09266","article-title":"Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1","volume":"137","author":"Nguyen","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib298","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/4297","article-title":"Post-transcriptional inducible gene regulation by natural antisense RNA","volume":"20","author":"Nishizawa","year":"2015","journal-title":"Front Biosci"},{"key":"10.1124\/pr.120.019554_bib299","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1126\/science.1060612","article-title":"Recognition of cognate transfer RNA by the 30S ribosomal subunit","volume":"292","author":"Ogle","year":"2001","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cell.2007.06.028","article-title":"The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila","volume":"130","author":"Okamura","year":"2007","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib301","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1101\/gad.1210204","article-title":"Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways","volume":"18","author":"Okamura","year":"2004","journal-title":"Genes Dev"},{"key":"10.1124\/pr.120.019554_bib302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/tnsci-2017-0001","article-title":"ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy","volume":"8","author":"Ottesen","year":"2017","journal-title":"Transl Neurosci"},{"key":"10.1124\/pr.120.019554_bib303","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev"},{"key":"10.1124\/pr.120.019554_bib304","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pr.120.019554_bib305","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1124\/dmd.113.052092","article-title":"Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1","volume":"41","author":"Pan","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.120.019554_bib306","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40425-019-0520-5","article-title":"Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer","volume":"7","author":"Papachristofilou","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1124\/pr.120.019554_bib307","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.120.019554_bib308","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1021\/ja1098325","article-title":"Identification of RNA pseudoknot-binding ligand that inhibits the -1 ribosomal frameshifting of SARS-coronavirus by structure-based virtual screening","volume":"133","author":"Park","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib309","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1021\/ja210088v","article-title":"Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching","volume":"134","author":"Parkesh","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib310","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1616569","article-title":"Targeting of antithrombin in hemophilia A or B with RNAi therapy","volume":"377","author":"Pasi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib311","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature08999","article-title":"Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay","volume":"465","author":"Pastor","year":"2010","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib312","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1073\/pnas.0911896107","article-title":"Inhibitor-induced structural change in the HCV IRES domain IIa RNA","volume":"107","author":"Paulsen","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib313","first-page":"2094","article-title":"Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors","volume":"6","author":"Pavco","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1124\/pr.120.019554_bib314","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nrg3594","article-title":"Gene regulation by antisense transcription","volume":"14","author":"Pelechano","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1124\/pr.120.019554_bib315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.molcel.2006.01.031","article-title":"Short RNAs repress translation after initiation in mammalian cells","volume":"21","author":"Petersen","year":"2006","journal-title":"Mol Cell"},{"key":"10.1124\/pr.120.019554_bib316","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1007\/s00253-019-09934-5","article-title":"Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs","volume":"103","author":"Petrek","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1124\/pr.120.019554_bib317","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.528","article-title":"MicroRNAs in non-small cell lung cancer: gene regulation, impact on cancer cellular processes, and therapeutic potential","volume":"7","author":"Petrek","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/pr.120.019554_bib318","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature14008","article-title":"Structure of influenza A polymerase bound to the viral RNA promoter","volume":"516","author":"Pflug","year":"2014","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib319","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1115079","article-title":"Inhibition of translational initiation by Let-7 MicroRNA in human cells","volume":"309","author":"Pillai","year":"2005","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib320","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1371\/journal.pbio.0030172","article-title":"A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal","volume":"3","author":"Plant","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1124\/pr.120.019554_bib321","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/1535370217731291","article-title":"MicroRNAs as biomarkers for clinical studies","volume":"243","author":"Pogribny","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1124\/pr.120.019554_bib322","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.447","article-title":"Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs","volume":"6","author":"Poirier","year":"2018","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/pr.120.019554_bib323","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-14-3321","article-title":"Multiplex genome-edited T-cell manufacturing platform for \u201coff-the-shelf\u201d adoptive T-cell immunotherapies","volume":"75","author":"Poirot","year":"2015","journal-title":"Cancer Res"},{"key":"10.1124\/pr.120.019554_bib324","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nprot.2009.67","article-title":"A generic protocol for the expression and purification of recombinant RNA in Escherichia coli using a tRNA scaffold","volume":"4","author":"Ponchon","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1124\/pr.120.019554_bib325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nmeth1058","article-title":"Recombinant RNA technology: the tRNA scaffold","volume":"4","author":"Ponchon","year":"2007","journal-title":"Nat Methods"},{"key":"10.1124\/pr.120.019554_bib326","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nmd.2009.10.013","article-title":"Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: implications for future clinical trials","volume":"20","author":"Popplewell","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1124\/pr.120.019554_bib327","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/dmd.119.087395","article-title":"Metabolism and disposition of volanesorsen, a 2\u2032-O-(2 methoxyethyl) antisense oligonucleotide, across species","volume":"47","author":"Post","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.120.019554_bib328","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bcp.2016.02.007","article-title":"Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen","volume":"107","author":"Prado","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.120.019554_bib329","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1158\/1535-7163.MCT-11-0152","article-title":"Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice","volume":"10","author":"Pramanik","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/pr.120.019554_bib330","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/hmg\/dds024","article-title":"Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila","volume":"21","author":"Qurashi","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.120.019554_bib331","doi-asserted-by":"crossref","first-page":"E7110","DOI":"10.1073\/pnas.1520883112","article-title":"Synthetic CRISPR RNA-Cas9-guided genome editing in human cells","volume":"112","author":"Rahdar","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib332","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/0192623316645860","article-title":"Preclinical safety evaluation in rats of a polymeric matrix containing an siRNA drug used as a local and prolonged delivery system for pancreatic cancer therapy","volume":"44","author":"Ramot","year":"2016","journal-title":"Toxicol Pathol"},{"key":"10.1124\/pr.120.019554_bib333","doi-asserted-by":"crossref","first-page":"14385","DOI":"10.1073\/pnas.0405913101","article-title":"Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity","volume":"101","author":"Rand","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib334","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cell.2005.10.020","article-title":"Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation","volume":"123","author":"Rand","year":"2005","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib335","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/mt.2016.93","article-title":"Preclinical Justification of pbi-shRNA EWS\/FLI1 Lipoplex (LPX) Treatment for Ewing\u2019s Sarcoma","volume":"24","author":"Rao","year":"2016","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib336","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","article-title":"Discovery of risdiplam, a selective survival of motor neuron-2 ( SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA)","volume":"61","author":"Ratni","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/pr.120.019554_bib337","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1021\/acs.jmedchem.6b00459","article-title":"Specific correction of alternative survival motor neuron 2 splicing by small molecules: discovery of a potential novel medicine to treat spinal muscular atrophy","volume":"59","author":"Ratni","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/pr.120.019554_bib338","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib339","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2019.3502","article-title":"Effect of 1 or 2 doses of inclisiran on low-density lipoprotein cholesterol levels: one-year follow-up of the ORION-1 randomized clinical trial","volume":"4","author":"Ray","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1124\/pr.120.019554_bib340","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nature07598","article-title":"A stress-responsive RNA switch regulates VEGFA expression","volume":"457","author":"Ray","year":"2009","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib341","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2015.03.004","article-title":"Structural basis for molecular discrimination by a 3\u2032,3\u2032-cGAMP sensing riboswitch","volume":"11","author":"Ren","year":"2015","journal-title":"Cell Rep"},{"key":"10.1124\/pr.120.019554_bib342","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1158\/1078-0432.CCR-16-1300","article-title":"Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition","volume":"23","author":"Ren","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1124\/pr.120.019554_bib343","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.06.023","article-title":"Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems","volume":"236","author":"Rezaee","year":"2016","journal-title":"J Control Release"},{"key":"10.1124\/pr.120.019554_bib344","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/jpet.113.212407","article-title":"Pharmacology of a central nervous system delivered 2\u2032-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates","volume":"350","author":"Rigo","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.120.019554_bib345","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/ja410344b","article-title":"Anti-frameshifting ligand reduces the conformational plasticity of the SARS virus pseudoknot","volume":"136","author":"Ritchie","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib346","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.drudis.2014.01.007","article-title":"How drug-like are \u2018ugly\u2019 drugs: do drug-likeness metrics predict ADME behaviour in humans?","volume":"19","author":"Ritchie","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1124\/pr.120.019554_bib347","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/mt.2010.289","article-title":"Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients","volume":"19","author":"Rittig","year":"2011","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib348","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/acschembio.7b01013","article-title":"Discovery of selective RNA-binding small molecules by affinity-selection mass spectrometry","volume":"13","author":"Rizvi","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pr.120.019554_bib349","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.mt.6300240","article-title":"2\u2032-O-methyl-modified RNAs act as TLR7 antagonists","volume":"15","author":"Robbins","year":"2007","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib350","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/344467a0","article-title":"Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA","volume":"344","author":"Robertson","year":"1990","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib351","first-page":"139","article-title":"Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"19","author":"Robinson","year":"2013","journal-title":"J Manag Care Pharm"},{"key":"10.1124\/pr.120.019554_bib352","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.celrep.2014.08.042","article-title":"SDF-1 inhibition targets the bone marrow niche for cancer therapy","volume":"9","author":"Roccaro","year":"2014","journal-title":"Cell Rep"},{"key":"10.1124\/pr.120.019554_bib353","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/dmd.119.088708","article-title":"Pharmacokinetic and drug metabolism properties of novel therapeutic modalities","volume":"47","author":"Rock","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.120.019554_bib354","first-page":"14","article-title":"Fomivirsen approved for CMV retinitis","volume":"4","author":"Roehr","year":"1998","journal-title":"J Int Assoc Physicians AIDS Care"},{"key":"10.1124\/pr.120.019554_bib355","doi-asserted-by":"crossref","first-page":"12508","DOI":"10.1073\/pnas.1605336113","article-title":"Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression","volume":"113","author":"Roy","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib356","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib357","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.120.019554_bib358","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s40265-014-0287-4","article-title":"Ataluren: first global approval","volume":"74","author":"Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1124\/pr.120.019554_bib359","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nchembio.2251","article-title":"Precise small-molecule recognition of a toxic CUG RNA repeat expansion","volume":"13","author":"Rzuczek","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pr.120.019554_bib360","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1124\/jpet.119.257287","article-title":"CRISPR\/Cas system for genome editing: progress and prospects as a therapeutic tool","volume":"370","author":"Sahel","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.120.019554_bib361","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.120.019554_bib362","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1126\/science.1129308","article-title":"A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene","volume":"313","author":"Salehi-Ashtiani","year":"2006","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib363","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ymthe.2019.07.001","article-title":"Circular RNAs: a novel class of functional RNA molecules with a therapeutic perspective","volume":"27","author":"Santer","year":"2019","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib364","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.120.019554_bib365","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa1807838","article-title":"Phase 1 trial of an RNA interference therapy for acute intermittent porphyria","volume":"380","author":"Sardh","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib366","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1016\/j.biomaterials.2010.05.043","article-title":"Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery","volume":"31","author":"Sch\u00e4fer","year":"2010","journal-title":"Biomaterials"},{"key":"10.1124\/pr.120.019554_bib367","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1128\/AAC.04895-14","article-title":"Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome","volume":"59","author":"Schedlbauer","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.120.019554_bib368","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/nbt915","article-title":"Approaches for the sequence-specific knockdown of mRNA","volume":"21","author":"Scherer","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib369","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ymthe.2019.03.002","article-title":"mRNA: a novel avenue to antibody therapy?","volume":"27","author":"Schlake","year":"2019","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib370","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymeth.2018.03.009","article-title":"Adventures with RNA graphs","volume":"143","author":"Schlick","year":"2018","journal-title":"Methods"},{"key":"10.1124\/pr.120.019554_bib371","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","article-title":"Asymmetry in the assembly of the RNAi enzyme complex","volume":"115","author":"Schwarz","year":"2003","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib372","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood-2012-09-456756","article-title":"The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys","volume":"121","author":"Schwoebel","year":"2013","journal-title":"Blood"},{"key":"10.1124\/pr.120.019554_bib373","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40265-020-01269-0","article-title":"Givosiran: first approval","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"key":"10.1124\/pr.120.019554_bib374","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1073\/pnas.1131959100","article-title":"Specificity of short interfering RNA determined through gene expression signatures","volume":"100","author":"Semizarov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib375","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature07642","article-title":"Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch","volume":"458","author":"Serganov","year":"2009","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib376","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2012.12.024","article-title":"A decade of riboswitches","volume":"152","author":"Serganov","year":"2013","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib377","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1021\/jm050815o","article-title":"SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain","volume":"48","author":"Seth","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/pr.120.019554_bib378","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.120.019554_bib379","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/gt.2017.79","article-title":"Market access of Spinraza (Nusinersen) for spinal muscular atrophy: intellectual property rights, pricing, value and coverage considerations","volume":"24","author":"Simoens","year":"2017","journal-title":"Gene Ther"},{"key":"10.1124\/pr.120.019554_bib380","doi-asserted-by":"crossref","first-page":"22","DOI":"10.15252\/emmm.201707850","article-title":"G-quadruplex-binding small molecules ameliorate C9orf72 FTD\/ALS pathology in vitro and in vivo","volume":"10","author":"Simone","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1124\/pr.120.019554_bib381","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0092-8674(83)90401-4","article-title":"Translational control of IS10 transposition","volume":"34","author":"Simons","year":"1983","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib382","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41467-017-01559-4","article-title":"Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers","volume":"8","author":"Sivaramakrishnan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/pr.120.019554_bib383","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1073\/pnas.69.11.3156","article-title":"Bidirectional transcription and the regulation of Phage lambda repressor synthesis","volume":"69","author":"Spiegelman","year":"1972","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib384","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1073\/pnas.75.8.3717","article-title":"Ribonuclease P: an enzyme with an essential RNA component","volume":"75","author":"Stark","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib385","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/mt.2016.188","article-title":"Eteplirsen approved for Duchenne muscular dystrophy: the FDA faces a difficult choice","volume":"24","author":"Stein","year":"2016","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib386","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","article-title":"FDA-approved oligonucleotide therapies in 2017","volume":"25","author":"Stein","year":"2017","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib387","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/CIRCULATIONAHA.112.104125","article-title":"Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease","volume":"126","author":"Stein","year":"2012","journal-title":"Circulation"},{"key":"10.1124\/pr.120.019554_bib388","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrm2352","article-title":"A structural understanding of the dynamic ribosome machine","volume":"9","author":"Steitz","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/pr.120.019554_bib389","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nchembio.596","article-title":"Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble","volume":"7","author":"Stelzer","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pr.120.019554_bib390","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.75.1.285","article-title":"Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide","volume":"75","author":"Stephenson","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib391","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3324\/haematol.2018.205930","article-title":"Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed\/refractory chronic lymphocytic leukemia","volume":"104","author":"Steurer","year":"2019","journal-title":"Haematologica"},{"key":"10.1124\/pr.120.019554_bib392","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/med.20081","article-title":"The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention","volume":"26","author":"Stevens","year":"2006","journal-title":"Med Res Rev"},{"key":"10.1124\/pr.120.019554_bib393","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1093\/nar\/gkq206","article-title":"The siRNA sequence and guide strand overhangs are determinants of in vivo duration of silencing","volume":"38","author":"Strapps","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib394","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bcp.13786","article-title":"A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier","volume":"85","author":"Sturm","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.120.019554_bib395","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1093\/nar\/gki731","article-title":"An atypical RNA pseudoknot stimulator and an upstream attenuation signal for -1 ribosomal frameshifting of SARS coronavirus","volume":"33","author":"Su","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib396","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS","volume":"83","author":"Su","year":"2014","journal-title":"Neuron"},{"key":"10.1124\/pr.120.019554_bib397","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.chembiol.2005.10.007","article-title":"Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine","volume":"12","author":"Sudarsan","year":"2005","journal-title":"Chem Biol"},{"key":"10.1124\/pr.120.019554_bib398","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1101\/gad.1140003","article-title":"An mRNA structure in bacteria that controls gene expression by binding lysine","volume":"17","author":"Sudarsan","year":"2003","journal-title":"Genes Dev"},{"key":"10.1124\/pr.120.019554_bib399","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6817-6_1","article-title":"Invention and early history of morpholinos: from pipe dream to practical products","volume":"1565","author":"Summerton","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.120.019554_bib400","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1093\/nar\/gkx135","article-title":"N1-methyl-pseudouridine in mRNA enhances translation through eIF2\u03b1-dependent and independent mechanisms by increasing ribosome density","volume":"45","author":"Svitkin","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib401","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40265-016-0657-1","article-title":"Eteplirsen: first global approval","volume":"76","author":"Syed","year":"2016","journal-title":"Drugs"},{"key":"10.1124\/pr.120.019554_bib402","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41565-018-0273-1","article-title":"Roadmap and strategy for overcoming infusion reactions to nanomedicines","volume":"13","author":"Szebeni","year":"2018","journal-title":"Nat Nanotechnol"},{"key":"10.1124\/pr.120.019554_bib403","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1021\/ja502754f","article-title":"Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays","volume":"136","author":"Sztuba-Solinska","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib404","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib405","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1073\/pnas.1310478110","article-title":"Efficient nonmeiotic allele introgression in livestock using custom endonucleases","volume":"110","author":"Tan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib406","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nsmb.2943","article-title":"Toll-like receptor 8 senses degradation products of single-stranded RNA","volume":"22","author":"Tanji","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/pr.120.019554_bib407","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1038\/s41598-019-40187-4","article-title":"Application of locked nucleic acid oligonucleotides for siRNA preclinical bioanalytics","volume":"9","author":"Thayer","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/pr.120.019554_bib408","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.jacc.2013.07.081","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Thomas","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.120.019554_bib409","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1021\/jacs.5b09974","article-title":"Emerging frontiers in drug delivery","volume":"138","author":"Tibbitt","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib410","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2005.02.005","article-title":"Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance","volume":"121","author":"Tu","year":"2005","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib411","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2018.10.038","article-title":"Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models","volume":"442","author":"Tu","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1124\/pr.120.019554_bib412","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.sbi.2005.05.003","article-title":"Riboswitches as versatile gene control elements","volume":"15","author":"Tucker","year":"2005","journal-title":"Curr Opin Struct Biol"},{"key":"10.1124\/pr.120.019554_bib413","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib414","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1093\/nar\/gkn902","article-title":"Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect","volume":"36","author":"Ui-Tei","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181748","article-title":"THPdb: database of FDA-approved peptide and protein therapeutics","volume":"12","author":"Usmani","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/pr.120.019554_bib416","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.120.019554_bib417","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e32834f33e8","article-title":"mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients","volume":"26","author":"Van Gulck","year":"2012","journal-title":"AIDS"},{"key":"10.1124\/pr.120.019554_bib418","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(98)00093-6","article-title":"Do natural antisense transcripts make sense in eukaryotes?","volume":"211","author":"Vanh\u00e9e-Brossollet","year":"1998","journal-title":"Gene"},{"issue":"Suppl 1","key":"10.1124\/pr.120.019554_bib419","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003495-199600511-00006","article-title":"Mechanism of action of streptogramins and macrolides","volume":"51","author":"Vannuffel","year":"1996","journal-title":"Drugs"},{"key":"10.1124\/pr.120.019554_bib420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drudis.2014.09.004","article-title":"Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(\u00ae) therapeutics","volume":"20","author":"Vater","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1124\/pr.120.019554_bib421","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1073\/pnas.1523975113","article-title":"Design of a small molecule against an oncogenic noncoding RNA","volume":"113","author":"Velagapudi","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib422","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.chembiol.2018.05.015","article-title":"Approved anti-cancer drugs target oncogenic non-coding RNAs","volume":"25","author":"Velagapudi","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1124\/pr.120.019554_bib423","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nchembio.1452","article-title":"Sequence-based design of bioactive small molecules that target precursor microRNAs","volume":"10","author":"Velagapudi","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pr.120.019554_bib424","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1074\/jbc.M210326200","article-title":"Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis","volume":"278","author":"Vickers","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.120.019554_bib425","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1188\/10.CJON.E10-E21","article-title":"Infusion reactions: diagnosis, assessment, and management","volume":"14","author":"Vogel","year":"2010","journal-title":"Clin J Oncol Nurs"},{"key":"10.1124\/pr.120.019554_bib426","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/1535-7163.MCT-16-0541","article-title":"Preclinical mammalian safety studies of EPHARNA (DOPC nanoliposomal EphA2-targeted siRNA)","volume":"16","author":"Wagner","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/pr.120.019554_bib427","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/med.2610060303","article-title":"Polyfunctional DNA intercalating agents","volume":"6","author":"Wakelin","year":"1986","journal-title":"Med Res Rev"},{"key":"10.1124\/pr.120.019554_bib428","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.chembiol.2017.03.014","article-title":"Dual-targeting small-molecule inhibitors of the Staphylococcus aureus FMN riboswitch disrupt riboflavin homeostasis in an infectious setting","volume":"24","author":"Wang","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1124\/pr.120.019554_bib429","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering","volume":"153","author":"Wang","year":"2013","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib430","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt.3408","article-title":"Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors","volume":"33","author":"Wang","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib431","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4155\/bio.15.234","article-title":"Advances in quantitative bioanalysis of oligonucleotide biomarkers and therapeutics","volume":"8","author":"Wang","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1124\/pr.120.019554_bib432","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.1520244113","article-title":"Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib433","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/jpet.115.225631","article-title":"Bioengineering novel chimeric microRNA-34a for prodrug cancer therapy: high-yield expression and purification, and structural and functional characterization","volume":"354","author":"Wang","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.120.019554_bib434","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/nar\/gkp864","article-title":"Selection of hyperfunctional siRNAs with improved potency and specificity","volume":"37","author":"Wang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib435","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrd.2018.93","article-title":"Principles for targeting RNA with drug-like small molecules","volume":"17","author":"Warner","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.120.019554_bib436","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.chembiol.2014.03.007","article-title":"Validating fragment-based drug discovery for biological RNAs: lead fragments bind and remodel the TPP riboswitch specifically","volume":"21","author":"Warner","year":"2014","journal-title":"Chem Biol"},{"key":"10.1124\/pr.120.019554_bib437","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/jpet.115.230300","article-title":"Comparative characterization of hepatic distribution and mRNA reduction of antisense oligonucleotides conjugated with triantennary N-acetyl galactosamine and lipophilic ligands targeting apolipoprotein B","volume":"357","author":"Watanabe","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.120.019554_bib438","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/nprot.2013.142","article-title":"Generation of targeted mouse mutants by embryo microinjection of TALEN mRNA","volume":"8","author":"Wefers","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1124\/pr.120.019554_bib439","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/CJI.0b013e3181a00068","article-title":"Direct injection of protamine-protected mRNA: results of a phase 1\/2 vaccination trial in metastatic melanoma patients","volume":"32","author":"Weide","year":"2009","journal-title":"J Immunother"},{"key":"10.1124\/pr.120.019554_bib440","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/mt.2015.138","article-title":"mRNA: fulfilling the promise of gene therapy","volume":"23","author":"Weissman","year":"2015","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib441","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.165.8.4710","article-title":"HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response","volume":"165","author":"Weissman","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.120.019554_bib442","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11362","article-title":"Targeting nuclear RNA for in vivo correction of myotonic dystrophy","volume":"488","author":"Wheeler","year":"2012","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib443","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-10-0655","article-title":"Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34","volume":"70","author":"Wiggins","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/pr.120.019554_bib444","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib445","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ymthe.2005.10.014","article-title":"RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues","volume":"13","author":"Wilber","year":"2006","journal-title":"Mol Ther"},{"key":"10.1124\/pr.120.019554_bib446","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/annonc\/mdt245","article-title":"A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients","volume":"24","author":"Wilgenhof","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1124\/pr.120.019554_bib447","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/10409230903307311","article-title":"The A-Z of bacterial translation inhibitors","volume":"44","author":"Wilson","year":"2009","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1124\/pr.120.019554_bib448","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrmicro3155","article-title":"Ribosome-targeting antibiotics and mechanisms of bacterial resistance","volume":"12","author":"Wilson","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/pr.120.019554_bib449","doi-asserted-by":"crossref","first-page":"13339","DOI":"10.1073\/pnas.0804276105","article-title":"The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning","volume":"105","author":"Wilson","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib450","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nature01145","article-title":"Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression","volume":"419","author":"Winkler","year":"2002","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib451","doi-asserted-by":"crossref","first-page":"15908","DOI":"10.1073\/pnas.212628899","article-title":"An mRNA structure that controls gene expression by binding FMN","volume":"99","author":"Winkler","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib452","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib453","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1126\/science.1207773","article-title":"Targeted genome editing across species using ZFNs and TALENs","volume":"333","author":"Wood","year":"2011","journal-title":"Science"},{"key":"10.1124\/pr.120.019554_bib454","first-page":"570","article-title":"FDA approves patisiran to treat hereditary transthyretin amyloidosis","volume":"14","author":"Wood","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/pr.120.019554_bib455","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mayocp.2019.08.021","article-title":"Effects of renal impairment on the pharmacokinetics, efficacy, and safety of inclisiran: an analysis of the ORION-7 and ORION-1 studies","volume":"95","author":"Wright","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1124\/pr.120.019554_bib456","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","article-title":"Correction of a genetic disease in mouse via use of CRISPR-Cas9","volume":"13","author":"Wu","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1124\/pr.120.019554_bib457","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/s41467-018-06522-5","article-title":"Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases","volume":"9","author":"Xu","year":"2018","journal-title":"Nat Commun"},{"key":"10.1124\/pr.120.019554_bib458","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biomaterials.2019.04.025","article-title":"Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis","volume":"210","author":"Xu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1124\/pr.120.019554_bib459","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1182\/blood-2019-01-895094","article-title":"Editing aberrant splice sites efficiently restores \u03b2-globin expression in \u03b2-thalassemia","volume":"133","author":"Xu","year":"2019","journal-title":"Blood"},{"key":"10.1124\/pr.120.019554_bib460","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","article-title":"CRISPR-mediated direct mutation of cancer genes in the mouse liver","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"key":"10.1124\/pr.120.019554_bib461","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1021\/ja507448y","article-title":"Inhibition of non-ATG translational events in cells via covalent small molecules targeting RNA","volume":"137","author":"Yang","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.120.019554_bib462","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12250-020-00243-0","article-title":"mRNA vaccines: possible tools to combat SARS-CoV-2","volume":"35","author":"Yi","year":"2020","journal-title":"Virol Sin"},{"key":"10.1124\/pr.120.019554_bib463","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.apsb.2019.11.001","article-title":"Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics","volume":"10","author":"Yi","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/pr.120.019554_bib464","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","article-title":"Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo","volume":"34","author":"Yin","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.120.019554_bib465","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/cts.12624","article-title":"Targeting RNA: a transformative therapeutic strategy","volume":"12","author":"Yin","year":"2019","journal-title":"Clin Transl Sci"},{"key":"10.1124\/pr.120.019554_bib466","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00253-020-10350-3","article-title":"Novel approaches for efficient in vivo fermentation production of noncoding RNAs","volume":"104","author":"Yu","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1124\/pr.120.019554_bib467","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.11.011","article-title":"RNA therapy: are we using the right molecules?","volume":"196","author":"Yu","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.120.019554_bib468","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1073\/pnas.75.1.280","article-title":"Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide","volume":"75","author":"Zamecnik","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib469","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(00)80620-0","article-title":"RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals","volume":"101","author":"Zamore","year":"2000","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib470","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2004.06.017","article-title":"Single processing center models for human Dicer and bacterial RNase III","volume":"118","author":"Zhang","year":"2004","journal-title":"Cell"},{"key":"10.1124\/pr.120.019554_bib471","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1073\/pnas.1905057117","article-title":"Translation of the intrinsically disordered protein \u03b1-synuclein is inhibited by a small molecule targeting its structured mRNA","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib472","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijpharm.2018.06.026","article-title":"Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo","volume":"547","author":"Zhang","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1124\/pr.120.019554_bib473","doi-asserted-by":"crossref","first-page":"D271","DOI":"10.1093\/nar\/gkh024","article-title":"DEG: a database of essential genes","volume":"32","author":"Zhang","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pr.120.019554_bib474","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jcph.1480","article-title":"Patisiran pharmacokinetics, pharmacodynamics, and exposure-response analyses in the phase 3 APOLLO trial in patients with hereditary transthyretin-mediated (hATTR) amyloidosis","volume":"60","author":"Zhang","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.120.019554_bib475","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcph.1553","article-title":"Pharmacokinetics of patisiran, the first approved RNA interference therapy in patients with hereditary transthyretin-mediated amyloidosis","volume":"60","author":"Zhang","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.120.019554_bib476","doi-asserted-by":"crossref","first-page":"13223","DOI":"10.1038\/ncomms13223","article-title":"Structures and stabilization of kinetoplastid-specific split rRNAs revealed by comparing leishmanial and human ribosomes","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/pr.120.019554_bib477","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci Adv"},{"key":"10.1124\/pr.120.019554_bib478","doi-asserted-by":"crossref","first-page":"26611","DOI":"10.1038\/srep26611","article-title":"Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/pr.120.019554_bib479","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bcp.2015.10.015","article-title":"Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth","volume":"98","author":"Zhao","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.120.019554_bib480","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.1073\/pnas.1314307110","article-title":"Mutant KRAS is a druggable target for pancreatic cancer","volume":"110","author":"Zorde Khvalevsky","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.120.019554_bib481","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd4685","article-title":"Clinical experiences with systemically administered siRNA-based therapeutics in cancer","volume":"14","author":"Zuckerman","year":"2015","journal-title":"Nat Rev Drug Discov"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724009803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724009803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.120.019554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:53:26Z","timestamp":1740765206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724009803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":481,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0031699724009803"],"URL":"https:\/\/doi.org\/10.1124\/pr.120.019554","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.120.019554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The Author(s)","name":"copyright","label":"Copyright"}]}}